Cargando…
Pathophysiological Mechanisms in Sclerosing Skin Diseases
Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines an...
Autores principales: | Eckes, Beate, Wang, Fang, Moinzadeh, Pia, Hunzelmann, Nicolas, Krieg, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563304/ https://www.ncbi.nlm.nih.gov/pubmed/28868289 http://dx.doi.org/10.3389/fmed.2017.00120 |
Ejemplares similares
-
Pharmacology and rationale for imatinib in the treatment of scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2013) -
Proteinuria in systemic sclerosis: reversal by ACE inhibition
por: Schuster, J., et al.
Publicado: (2013) -
Cell-matrix interactions in dermal repair and scarring
por: Eckes, Beate, et al.
Publicado: (2010) -
Editorial: Pathophysiology of Sensitive Skin
por: Misery, Laurent, et al.
Publicado: (2020) -
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)